BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22900931)

  • 1. Association of HLA mismatch with death with a functioning graft after kidney transplantation: a collaborative transplant study report.
    Opelz G; Döhler B
    Am J Transplant; 2012 Nov; 12(11):3031-8. PubMed ID: 22900931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ceppellini Lecture 2012: collateral damage from HLA mismatching in kidney transplantation.
    Opelz G; Döhler B
    Tissue Antigens; 2013 Oct; 82(4):235-42. PubMed ID: 24461002
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of HLA compatibility in recipients of kidneys from expanded criteria donors: A Collaborative Transplant Study Report.
    Echterdiek F; Latus J; Döhler B; Schwenger V; Süsal C
    Int J Immunogenet; 2021 Apr; 48(2):201-210. PubMed ID: 32945128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report.
    Opelz G; Döhler B
    Transplantation; 2010 Aug; 90(3):292-7. PubMed ID: 20548266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antibody induction on transplant outcomes in human leukocyte antigen zero-mismatch deceased donor kidney recipients.
    Kuo HT; Huang E; Emami S; Pham PT; Wilkinson AH; Danovitch GM; Bunnapradist S
    Transplantation; 2012 Mar; 93(5):493-502. PubMed ID: 22306574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well-Matched Deceased Donor Transplants.
    Opelz G; Döhler B; Middleton D; Süsal C;
    Transplantation; 2017 Nov; 101(11):2789-2792. PubMed ID: 28471872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Risk of Transplant Failure With HLA Mismatch in First Adult Kidney Allografts From Deceased Donors.
    Williams RC; Opelz G; McGarvey CJ; Weil EJ; Chakkera HA
    Transplantation; 2016 May; 100(5):1094-102. PubMed ID: 26901078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human leukocyte antigen mismatches associated with increased risk of rejection, graft failure, and death independent of initial immunosuppression in renal transplant recipients.
    Lim WH; Chadban SJ; Clayton P; Budgeon CA; Murray K; Campbell SB; Cohney S; Russ GR; McDonald SP
    Clin Transplant; 2012; 26(4):E428-37. PubMed ID: 22672477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kidney transplantation in the US: an analysis of the OPTN/UNOS registry.
    Freitas MC
    Clin Transpl; 2011; ():1-16. PubMed ID: 22755397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of amino acid mismatch in the UNOS 2007 dataset.
    Sasaki N; Idica A; Hall B; Terasaki P
    Clin Transpl; 2007; ():241-54. PubMed ID: 18642455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of amino acid mismatch in the UNOS dataset.
    Sasaki N; El-Awar N; Idica A
    Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful cadaveric renal transplantation of patients highly sensitized to HLA Class I antigens.
    Bryan CF; Shield CF; Pierce GE; Warady BA; Aeder MI; Martinez J; Luger AM; Nelson PW; Ross G; Muruve N; Mitchell SI
    Clin Transplant; 2000 Feb; 14(1):79-84. PubMed ID: 10693641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transplantation results of completely HLA-mismatched living and completely HLA-matched deceased-donor kidneys are comparable.
    Laging M; Kal-van Gestel JA; Haasnoot GW; Claas FH; van de Wetering J; Ijzermans JN; Weimar W; Roodnat JI
    Transplantation; 2014 Feb; 97(3):330-6. PubMed ID: 24202143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of HLA cross-reactive group matching on graft survival in deceased donor kidney recipients.
    Lazda VA; Mozes MF
    Transplant Proc; 2005 Mar; 37(2):661-3. PubMed ID: 15848493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between specific HLA combinations and probability of kidney allograft loss: the taboo concept.
    Doxiadis II; Smits JM; Schreuder GM; Persijn GG; van Houwelingen HC; van Rood JJ; Claas FH
    Lancet; 1996 Sep; 348(9031):850-3. PubMed ID: 8826810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney transplantation, the Halifax experience.
    Belitsky P; MacDonald AS; Lawen J; McAlister V; Bitter-Suermann H; Kiberd B; West K; Sketris I
    Clin Transpl; 1996; ():231-40. PubMed ID: 9286572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades.
    Opelz G; Döhler B
    Transplantation; 2007 Jul; 84(2):137-43. PubMed ID: 17667803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.
    Philogene MC; Amin A; Zhou S; Charnaya O; Vega R; Desai N; Neu AM; Pruette CS
    Pediatr Nephrol; 2020 Jan; 35(1):83-94. PubMed ID: 31599339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype.
    Bryan CF; Martinez J; Muruve N; Nelson PW; Pierce GE; Ross G; Shield CF; Warady BA; Aeder MI; Harrell KM; Helling TS; Luger AM
    Clin Transplant; 2001; 15 Suppl 6():28-35. PubMed ID: 11903383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Comparison of HLA Molecular Mismatch Methods to Determine HLA Immunogenicity.
    Wiebe C; Kosmoliaptsis V; Pochinco D; Taylor CJ; Nickerson P
    Transplantation; 2018 Aug; 102(8):1338-1343. PubMed ID: 29443827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.